At a glance
ClinicalIndex Comparison RecordN/ACompleted· 248 enrolled
Drug / intervention
QLV based implant strategy +1 moredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Cardiac Resynchronization Therapy (CRT) Implant Strategy Using the Longest Electrical Delay for Non-left Bundle Branch Block Patients (ENHANCE CRT). A Prospective, Randomized, Postmarket, Pilot Study.
In Brief
A clinical study evaluating QLV based implant strategy and Standard of care implant strategy for Non-left Bundle Branch Block and Ischemic or Non-ischemic Cardiomyopathy. Completed, enrolled 248 participants across 32 sites.
Detailed Summary
The purpose of this study is to analyze the effect of left ventricular lead pacing location in the non-left bundle branch block (non-LBBB) heart failure patient population. The left ventricular lead pacing location will be guided by either the pacing site with the largest amount of dyssynchrony as measured by the LV electrical delay (QLV) or the physician's standard of care implant approach.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesUnited States
Collaborators--
Timeline
N/ACompletedFinished
2014201520162017201820192020202120222023202420252026
Enrollment StartNov 2013
First PostedNov 2013
Primary CompletionJan 2018
TodayJul 2026
First PostedNov 13, 2013
Enrollment StartNov 1, 2013
Primary CompletionJan 1, 2018
TodayJul 2, 2026
Enrollment to primary: 4.2 yearsPosted 12.6 years ago
Interventions
QLV based implant strategydevice
Standard of care implant strategydevice